Moberg Pharma (Sweden) Analysis
| MOB Stock | SEK 18.11 0.60 3.21% |
Moberg Pharma AB is overvalued with Real Value of 15.92 and Hype Value of 18.11. The main objective of Moberg Pharma stock analysis is to determine its intrinsic value, which is an estimate of what Moberg Pharma AB is worth, separate from its market price. There are two main types of Moberg Pharma's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Moberg Pharma's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Moberg Pharma's stock to identify patterns and trends that may indicate its future price movements.
The Moberg Pharma stock is traded in Sweden on Stockholm Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Sweden. Moberg Pharma is usually not traded on NationalDay, International Workers ' Day, St . John 's Day, All Saints ' Day, Christmas Eve, Christmas Day, Boxing Day, New Year 's Day, Epiphany, Good Friday, Easter Sunday, Easter Monday. Moberg Stock trading window is adjusted to Europe/Stockholm timezone.
Moberg |
Moberg Stock Analysis Notes
About 18.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.42. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Moberg Pharma AB recorded a loss per share of 0.36. The entity last dividend was issued on the 4th of November 2019. The firm had 10:1 split on the 24th of May 2023. Moberg Pharma AB , a pharmaceutical company, develops and commercializes medical products for pain and skin conditions in Europe, the United States, and internationally. Moberg Pharma AB was incorporated in 2006 and is headquartered in Bromma, Sweden. Moberg Pharma operates under Drug ManufacturersSpecialty Generic classification in Sweden and is traded on Stockholm Stock Exchange. It employs 11 people. To find out more about Moberg Pharma AB contact the company at 46 8 52 23 07 00 or learn more at https://www.mobergpharma.se.Moberg Pharma AB Investment Alerts
| Moberg Pharma AB generated a negative expected return over the last 90 days | |
| Moberg Pharma AB has high historical volatility and very poor performance | |
| Moberg Pharma AB has accumulated about 36.6 M in cash with (15.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.82. | |
| Roughly 18.0% of the company outstanding shares are owned by corporate insiders |
Moberg Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 272.28 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Moberg Pharma's market, we take the total number of its shares issued and multiply it by Moberg Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 27th of November, Moberg Pharma secures the Risk Adjusted Performance of (0.01), standard deviation of 8.69, and Mean Deviation of 4.21. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Moberg Pharma AB, as well as the relationship between them.Moberg Pharma AB Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Moberg Pharma middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Moberg Pharma AB. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Moberg Pharma Outstanding Bonds
Moberg Pharma issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Moberg Pharma AB uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Moberg bonds can be classified according to their maturity, which is the date when Moberg Pharma AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Moberg Pharma Predictive Daily Indicators
Moberg Pharma intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Moberg Pharma stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 10580.13 | |||
| Daily Balance Of Power | (0.66) | |||
| Rate Of Daily Change | 0.97 | |||
| Day Median Price | 18.41 | |||
| Day Typical Price | 18.31 | |||
| Price Action Indicator | (0.60) | |||
| Period Momentum Indicator | (0.60) |
Moberg Pharma Forecast Models
Moberg Pharma's time-series forecasting models are one of many Moberg Pharma's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Moberg Pharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Moberg Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Moberg Pharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Moberg shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Moberg Pharma. By using and applying Moberg Stock analysis, traders can create a robust methodology for identifying Moberg entry and exit points for their positions.
Moberg Pharma AB , a pharmaceutical company, develops and commercializes medical products for pain and skin conditions in Europe, the United States, and internationally. Moberg Pharma AB was incorporated in 2006 and is headquartered in Bromma, Sweden. Moberg Pharma operates under Drug ManufacturersSpecialty Generic classification in Sweden and is traded on Stockholm Stock Exchange. It employs 11 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Moberg Pharma to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Analyzer Now
Portfolio AnalyzerPortfolio analysis module that provides access to portfolio diagnostics and optimization engine |
| All Next | Launch Module |
Additional Tools for Moberg Stock Analysis
When running Moberg Pharma's price analysis, check to measure Moberg Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Moberg Pharma is operating at the current time. Most of Moberg Pharma's value examination focuses on studying past and present price action to predict the probability of Moberg Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Moberg Pharma's price. Additionally, you may evaluate how the addition of Moberg Pharma to your portfolios can decrease your overall portfolio volatility.